Collectively, the observations in TRAF3-LKO mice suggest that HFD-induced obesity, insulin resistance and glucose metabolic disturbance are inhibited by a liver-specific deficiency of TRAF3. The gene discussed is TRAF3; the disease is obesity due to melanocortin 4 receptor deficiency.